Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of treatment satisfaction misalignment between Japanese psoriasis patients and their physicians - Japanese psoriasis patients and their physicians do not share the same treatment satisfaction levels.
Okubo Y, Torisu-Itakura H, Hanada T, Aranishi T, Inoue S, Ohtsuki M. Okubo Y, et al. Among authors: torisu itakura h. Curr Med Res Opin. 2021 Jul;37(7):1103-1109. doi: 10.1080/03007995.2021.1920898. Epub 2021 May 19. Curr Med Res Opin. 2021. PMID: 33896280
Relationship Between Rapid Skin Clearance and Quality of Life Benefit: Post Hoc Analysis of Japanese Patients with Moderate-to-Severe Psoriasis Treated with Ixekizumab (UNCOVER-J).
Honma M, Cai Z, Burge R, Zhu B, Yotsukura S, Torisu-Itakura H. Honma M, et al. Among authors: torisu itakura h. Dermatol Ther (Heidelb). 2020 Dec;10(6):1397-1404. doi: 10.1007/s13555-020-00441-4. Epub 2020 Sep 10. Dermatol Ther (Heidelb). 2020. PMID: 32910360 Free PMC article.
Long-term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open-label, phase 3 study (UNCOVER-J).
Okubo Y, Mabuchi T, Iwatsuki K, Elmaraghy H, Torisu-Itakura H, Morisaki Y, Nakajo K. Okubo Y, et al. J Eur Acad Dermatol Venereol. 2019 Feb;33(2):325-332. doi: 10.1111/jdv.15287. Epub 2018 Nov 15. J Eur Acad Dermatol Venereol. 2019. PMID: 30317671 Free PMC article. Clinical Trial.
Long-term efficacy and safety results from an open-label phase III study (UNCOVER-J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab.
Umezawa Y, Torisu-Itakura H, Morisaki Y, ElMaraghy H, Nakajo K, Akashi N, Saeki H; Japanese Ixekizumab Study Group. Umezawa Y, et al. Among authors: torisu itakura h. J Eur Acad Dermatol Venereol. 2019 Mar;33(3):568-576. doi: 10.1111/jdv.15292. Epub 2018 Nov 13. J Eur Acad Dermatol Venereol. 2019. PMID: 30325534 Free PMC article. Clinical Trial.
24 results